# 4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?

> **NCT00067756** · PHASE2 · COMPLETED · sponsor: **University of Florida** · enrollment: 12 (actual)

## Conditions studied

- Alpha 1-Antitrypsin Deficiency

## Interventions

- **DRUG:** 4-PBA

## Key facts

- **NCT ID:** NCT00067756
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2003-10
- **Final completion:** 2003-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-01-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00067756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00067756, "4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00067756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*